ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

DYAI Dyadic International Inc

1.43
-0.07 (-4.67%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Dyadic International Inc DYAI NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.07 -4.67% 1.43 13:00:08
始値 安値 高値 終値 前日終値
1.48 1.40 1.4999 1.43 1.50
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0105:30GLOBEDyadic to Report First Quarter 2024 Financial Results on..
2024/3/2905:00GLOBEDyadic Reports 2023 Full Year Results and Recent Company..
2024/3/2821:30GLOBEDyadic Announces Change in Board and Management Leadership..
2024/3/2721:30GLOBEDyadic to Attend Industry Events in April
2024/3/2621:30GLOBEDyadic Announces Publication of C1 Monoclonal Antibody in..
2024/3/2121:30GLOBEDyadic to Attend Future Food Tech Event March 21 – 22, 2024..
2024/3/1505:30GLOBEDyadic to Report Full Year 2023 Financial Results and Host..
2024/3/1122:57GLOBECORRECTION – Dyadic Announces Closing of Private Placement..
2024/3/1121:45EDGAR2Form 8-K - Current report
2024/3/1121:30GLOBEDyadic Announces Closing of Private Placement of $6.0..
2024/3/0122:30GLOBEDyadic to Attend Industry Events in March
2024/2/2822:30GLOBEDyadic Announces Strategic Partnership Agreement to..
2024/2/2122:30GLOBEDyadic Advances Collaboration with Israel Institute for..
2024/2/1406:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1322:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
2024/2/0622:30GLOBEDyadic Announces Research and Development Collaboration..
2024/2/0206:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0122:30GLOBEDyadic to Attend BIO CEO & Investor Conference and European..
2024/1/0510:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0222:30GLOBEDyadic to Attend J.P. Morgan 42nd Annual Healthcare..
2023/11/3022:30GLOBEDyadic Attends Investor Events in December
2023/11/2922:30GLOBEDyadic Announces Top-Line Results from its Successful Phase..
2023/11/2022:30GLOBEDyadic’s C1 Platform to be Used to Produce Vaccines..
2023/11/0906:09EDGAR2Form 8-K - Current report
2023/11/0906:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:00GLOBEDyadic Announces Third Quarter 2023 Financial Results and..
2023/10/3021:30GLOBEDyadic to Present at Industry Events in November
2023/10/2605:30GLOBEDyadic to Report Third Quarter 2023 Financial Results on..
2023/10/0921:30GLOBEDyadic Appoints Doug Pace to Its Executive Leadership Team
2023/10/0705:20EDGAR2Form 8-K - Current report
2023/10/0705:10EDGAR2Form 8-K - Current report
2023/10/0521:30GLOBEDyadic’s C1 Platform Selected by the Vaccine and..
2023/9/2921:30GLOBEDyadic to Present at Industry and Investor Events in October
2023/9/2621:30GLOBEDyadic and bYoRNA Announce a Collaboration Targeting the..
2023/9/1921:30EDGAR2Form 8-K - Current report
2023/9/1921:00GLOBEDyadic Announces Development and License Agreement to..
2023/9/1305:30GLOBEDyadic to Present at BioProcess International
2023/8/2813:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/1005:10EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/1005:08EDGAR2Form 8-K - Current report
2023/8/1005:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

最近閲覧した銘柄

Delayed Upgrade Clock